This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
